StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > FYI: Background and information for interested readers...

<< Previous

Bullboard Posts

Next >>

Comment by cactuseskimoon Apr 14, 2021 9:59am

103 Views

Post# 32992007

RE:RE:RE:FYI: Background and information for interested readers...

Okay, you're right. The company never had a big change of direction. It was the stock price that did!

gojotv! wrote: The company never had a "big change of direction".
The idea that there was to be a takeover was speculation, and was never put out by management.
They said they would launch Aristotle, and they did.
They said they were going for the "employer" market, and they will.
They said they're going for FDA recognition in a year or two and they will. We don't have it yet, so the tests have to be done in-house. Those are the rules. That has always been the Law.
Anyone pretending to be surprised wasn't paying attention.
This is the way to go if we want to get Aristotle first to market, and not wait a couple of years and have to do a financing to get FDA approval.
It's all here under "Definition and Use of Laboratory Developed Tests":

https://www.ascp.org/content/docs/default-source/policy-statements/ascp-pdft-pp-regulation-of-ltds.pdf?sfvrsn=0

cactuseskimo wrote:
No bad news? No bad news!? The company does a big change of direction, pisses off their analysts, drops over 50%, and gets their target dropped from 4.00 to 1.25. But yeah, other than that, the news is all good!!!

Folks, I don't care if you're long or short, but for the love of saint pete, do your own DD and don't trust clowns like this guy.

gojotv! wrote: The bashers on this board will have you believe that there's been bad news about this company, but the opposite is true. Do your DD.
The crash in share price of two weeks ago began BEFORE news and financials were released.
in fact, bashers got VERY upset when the company didn't release until after market close, probably because it exposed their stock manipulation for what it was... a concerted effort by a small group of bashers represented by a slew of new aliases., and whose posts were so outrageously offensive, slanderous and/or untruthful that they were repeatedly banned. Notice who on this board is supplying you with information, and who is just here to bully, lie, harrass and attack those posters who are posting facts. That will tell you who to trust.
Now, watch as those posters drown THIS post out and bury it pages back before opening of the trading day with repeated, empty posts of theirs.
Those are the people you shouldn't trust.
There. Now you're up to speed
GLTA!